Loading the player… U.S. regulators on Monday added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it’s not entirely clear the shot caused the problem. The Food and Drug Administration announced the new warning, flagging reports of Guillain-Barre syndrome, an immune system… Read More: FDA adds warning about rare reaction to J&J COVID-19 vaccine »
ORLANDO, FLORIDA, UNITED STATES – 2021/04/10: Johnson & Johnson COVID-19 vial and box seen at a vaccination site. Doses of the Johnson & Johnson vaccine are being administered throughout the state of Florida despite a small number of patients who have experienced adverse reactions, including blood clots. (Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images)… Read More: J&J, AstraZeneca explore modifying Covid vaccines in response to rare… »
New analysis finds infections started to fall in 2013, but older gay men lag behind An analysis of HIV diagnoses and incidence in English gay and bisexual men by Dr Francesco Brizzi and colleagues from the Medical Research Council has found that new HIV infections fell by more than two-thirds between 2013 and 2018. If… Read More: HIV infection may become rare in UK gay men by… »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More: Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone)… »